Equities

EKF Diagnostics Holdings PLC

EKF:LSE

EKF Diagnostics Holdings PLC

Health CareMedical Equipment and Services
  • Price (GBX)28.05
  • Today's Change0.45 / 1.63%
  • Shares traded139.03k
  • 1 Year change0.18%
  • Beta0.4021
Data delayed at least 20 minutes, as of Apr 29 2024 13:19 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year EKF Diagnostics Holdings PLC had revenues fall -21.05% from 66.64m to 52.61m, though the company grew net income from a loss of 10.10m to a gain of 2.35m.
Gross margin46.45%
Net profit margin5.19%
Operating margin3.96%
Return on assets3.21%
Return on equity3.35%
Return on investment3.73%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at EKF Diagnostics Holdings PLC fell by 3.85m. However, the company earned 6.31m from its operations for a Cash Flow Margin of 12.00%. In addition the company used 5.64m on investing activities and also paid 3.65m in financing cash flows.
Cash flow per share0.0187
Price/Cash flow per share14.73
Book value per share0.1479
Tangible book value per share0.0813
More ▼

Balance sheet in GBPView more

EKF Diagnostics Holdings PLC has a Debt to Total Capital ratio of 5.67%, a higher figure than the previous year's 0.73%.
Current ratio2.69
Quick ratio1.77
Total debt/total equity0.0611
Total debt/total capital0.0567
More ▼

Growth rates in GBP

Year on year, growth in earnings per share excluding extraordinary items increased 123.45%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)1.69%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)-25.06
EPS (TTM) vs
TTM 1 year ago		123.27
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.